Skip to search formSkip to main contentSkip to account menu

indobufen

Known as: 2-(4-(1-oxo-2-isoindolinyl)phenyl)butyric acid, 4-(1,3-Dihydro-1-oxo-2H-isoindol-2-yl)-alpha-ethylbenzeneacetic acid, 4-(1,3-dihydro-1-oxo-2H-isoindol-2-yl) alpha- ethylbenzeneacetic acid 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Cyclooxygenase InhibitorsIsoindolesPhenylbutyratesPlatelet Aggregation Inhibitors

Narrower (2)

IbustrinK 3920
Indobufen Sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Stereoselective pharmacokinetics of indobufen from tablets and intramuscular injections in man.
The influence of administration route (oral or intramuscular (i.m.)) on the pharmacokinetics of total indobufen (INDB… 
1997
1997
A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
Two treatments, based on either ticlopidine or indobufen at their optimal individual daily dose (median dose: 250 and 200 mg/day… 
1997
1997
Effects of Indobufen and Pentoxifylline on Walking Capacity and Hemostasis in Patients with Intermittent Claudication: Results of Six Months of Treatment
Seventy-one patients with peripheral arterial occlusive disease (PAOD) were random ized into two groups of different treatment… 
1996
1996
Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.
We evaluated the effectiveness of indobufen administration in reducing neutrophil activation in a clinical model of ischemia… 
1995
1995
Anaesthesia and Autologous Transfusion
The anaesthesiologist plays a central role in co-ordinating the combined application of the various blood saving techniques. In… 
1993
1993
Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
The objective of the study was to evaluate the efficacy and safety of indobufen compared with placebo in the treatment of… 
1993
1993
[The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
A randomized clinical study was conducted to compare the effect of "conventional" antiaggregation therapy (ASA plus dipyridamole… 
1985
1985
Microthrombus formation on hemodialysis membranes: a placebo controlled randomized trail of two doses of Indobufen.
The role of Indobufen in preventing the formation of microthrombi on hemodialysis membranes has been investigated in 18 patients… 
1984
1984
Indobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol.
This study assessed the possible interactions of the cyclooxygenase inhibitor indobufen with one sulphonylurea, glipizide, and… 
1981
1981
Inhibition of Platelet Aggregation in Man by Indobufen (K 3920)
A complete crossover trial was undertaken in six healthy volunteers to gain information on dose-effect responses to indobufen by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)